Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system. The FDA investigational device exemption (IDE) trial evaluates the safety and efficacy of Aventus for the treatment of pulmonary embolism (PE). Aventus features proprietary tissue-sensing technology. It provides operators … [Read more...] about Inquis Medical completes enrollment in IDE study of thrombectomy system
